New Cedars-Sinai Cancer Center to Include Varian TrueBeam Technology

Cedars-Sinai Cancer Center pic
Cedars-Sinai Cancer Center
Image: cedars-sinai.edu

Integrated Oncology Network (ION) CEO and founder Jeffrey Goffman leads a Corona del Mar, California-based company that partners with hospitals and physicians in need of financial, management, and strategic assistance. Under the direction of Jeffrey Goffman, ION recently collaborated with the nonprofit hospital Cedars-Sinai to establish a new oncology treatment center in Beverly Hills. In addition to the usual high standard of care offered by Cedars-Sinai, the center will feature Varian TrueBeam linear accelerator technology.

Designed for high-precision treatments, the TrueBeam system brings leading-edge cancer care to patients and advances the fight against cancer. The fully integrated system offers image-guided radiotherapy and radiosurgery, allowing oncologists to treat cancer throughout the body while delivering accurate dose rates. TrueBeam also enhances safety and reduces operation times through an automated workflow that utilizes intuitive visual cues and streamlined imaging.

TrueBeam supports currently accepted advanced treatment forms such as Stereotactic Body Radiation Therapy. Additionally, a history of reliable technology updates help the TrueBeam system maintain its edge in the field of cancer treatment and gives oncologists the peace of mind that the system will be available and effective in the future.

Wings for Crossover Auctions Off Taylor Swift Tickets

Wings for Crossover pic
Wings for Crossover
Image: biddingowl.com

A veteran health care executive, Jeffrey Goffman brings more than three decades of experience to his current position as the founder, chairman, and chief executive officer of Integrated Oncology Network, LLC (ION). In addition to his role with ION, Jeffrey Goffman supports a range of nonprofit and charitable organizations, including serving as a board member for Wings for Crossover.

Founded in June of 2013, Wings for Crossover is a 501(c)(3) organization created to support Crossover International Academy, an educational institution for orphans and rescued child-slaves in Ghana. Since its founding, Wings for Crossover has worked to build new structures at the academy, develop food security and sustainable income programs, and create innovative educational opportunities for Crossover students.

To raise funds for the academy, Wings for Crossover hosts a number of events and benefits throughout the year. In July and August of 2015, the nonprofit group held an auction for VIP tickets to a Taylor Swift show at the Staples Center in Los Angeles. The premier package up for auction was five tickets for a private suite to watch Swift’s performance during her “1989” tour. The package also featured access to VIP parking and gate entrance. Other items up for bid included a signed, handmade hat from Pharrell Williams’ personal collection.

Cancer Survivors Top 15 Million

Oncology Network, LLC pic
Oncology Network, LLC
Image: ion-llc.com

An entrepreneur with experience leading several companies, Jeffrey Goffman cofounded Integrated Oncology Network, LLC, in 2009. The company provides management advice to oncologists, cancer centers, and hospitals nationwide. Jeffrey Goffman also previously founded OnCURE Medical Corp., a provider of outpatient radiation oncology treatment.

Recent data reveal that more than 15.5 million Americans are cancer survivors.
In addition to the current figures, projections reveal that cancer survivors could top 20 million as soon as 2026, according a recent study in the CA: A Cancer Journal for Clinicians. The study was conducted as a collaborative effort between the National Cancer Institute and the American Cancer Society.

Almost half of the survivors counted in the study are over the age of 70, and more than half of all survivors were diagnosed with cancer within the past decade.

For the purposes of the study, those who are defined as cancer survivors are individuals who either have a history of the disease or are still in treatment but considered cancer-free.

Child Labor and Ghana

Crossover International Academy pic
Crossover International Academy
Image: wingsforcrossover.org

Jeffrey Goffman, a businessman leading Integrated Oncology Network as CEO, supports Wings for Crossover in his capacity as board member. With the help of stakeholders like Jeffrey Goffman, the nonprofit organization helps educate children impacted by slavery in Ghana, Africa, through its Crossover International Academy.

According to information from the Ghana Statistical Service, nearly 2 million children in Ghana ranging in age from five years to 17 years old work in hazardous labor environments. Many have been pressed into conditions akin to slavery, especially within the fishing industry. For instance, in 2015, more than 40 young people were saved from working as slaves for a fishing enterprise on Volta Lake.

However, as suggested by the United States Department of Labor 2014 Findings on the Worst Forms of Child Labor – Ghana, the fishing industry is not the only one contributing to child labor problems. Cocoa producers, for example, employ nearly a million children and an estimated 95 percent of those children labor in hazardous conditions.

Understanding Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy pic
Duchenne Muscular Dystrophy
Image: WebMD.com

A philanthropist and CEO in the healthcare management sector, Jeffrey Goffman serves as chairman of the Board of Directors with CureDuchenne. In his leadership role, Jeffrey Goffman helps the nonprofit organization in its efforts to find life-saving treatments for Duchenne muscular dystrophy.

Muscular dystrophy represents not a single disease, rather it functions as a category encompassing several genetic conditions with progressive symptoms related to muscle atrophy. Some muscular dystrophies begin in adulthood, while others begin in childhood. Duchenne muscular dystrophy is a childhood disease that almost always affects boys.

Symptoms of Duchenne muscular dystrophy can start appearing in infancy and often get worse with time. Muscle weakness, a hallmark of the disease, usually begins in the lower extremities. Eventually, children with the condition lose their ability to walk and may develop breathing as well as cardiovascular problems by early adulthood. Moreover, Duchenne muscular dystrophy may cause intellectual disabilities.

Though there is no cure for the disease, researchers are working on gene therapies, some of which are in early human clinical trials.

About Covenant Health Outpatient Radiation Treatment Center

The co-founder of Integrated Oncology Network, LLC (ION), Jeffrey Goffman was named to the Barney School of Business Hall of Fame in 2014 for his work in national radiation oncology management and cancer center development. Jeffrey Goffman continues to impact the field of oncology by creating partnerships with companies such as Covenant Health.

In September of 2015, ION, subsidiary SightLine Health, LLC, and Covenant Health announced its plans to open Covenant Health Outpatient Radiation Treatment Center in Lubbock, Texas. The facility, supported by the Joe Arrington Cancer Research and Treatment Center, will enhance Covenant Health oncology services by making it more accessible in the community. Health care professionals will have use of modern technologies, like image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT). The latter delivers external beam radiation therapy with precision. IGRT increases IMRT’s effectiveness by sending high doses of radiation directly to treatment areas. This reduces radiation exposure to surrounding tissues.

To learn more about ION’s partnerships, visit http://www.ion-llc.com.

Duchenne and the Mission of CureDuchenne

After receiving his BS in accounting from the University of Hartford’s Barney School of Business, Jeffrey Goffman earned his certified public accountant license and spent 14 years in public accounting. Currently the chairman and CEO of Integrated Oncology Network, LLC, an oncology management services and operator venture he started in 2008, he serves on the Board of Affiliated PET Systems, LLC, a firm he co-founded in 2001. Jeffrey Goffman generously supports several charities, including CEOs Against Cancer, Wings for Crossover, and CureDuchenne.

The most common and severe form of muscular dystrophy, Duchenne typically occurs in boys, with initial symptoms appearing around age 2 or 3. The muscle weakness that characterizes the disease is caused by a loss of dystrophin, a component of muscle tissue that gives muscles their stability. As boys with Duchenne grow older, they grow weaker, and even the simplest tasks become increasingly more difficult. They are usually confined to a wheelchair by age 12 and rarely live past their mid-20s, because by then the heart and muscles that regulate breathing become too weak to function.

There are currently about 300,000 boys with Duchenne worldwide, about 20,000 of whom live in the United States. First identified in 1986, the disorder’s mechanics have been extensively investigated. Gene replacement therapies, RNA-based technology, and pharmacological interventions all show promise as therapeutic approaches. Despite this, there’s still no cure for the disease.

CureDuchenne was founded in 2003 by the parents of a boy who was diagnosed with Duchenne. When he was diagnosed, they learned that because so few boys have the disorder—about one in 3,500—it doesn’t command a great deal of attention within the medical and pharmacological research industries. They established CureDuchenne, whose mission is its name, to raise public awareness of this devastating disease.